ArticlePloS one2023
RVCNet: A hybrid deep neural network framework for the diagnosis of lung diseases.
Article in PloS one, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 19 citations in OpenAlex.
- TL-PneuNet: a transfer learning-based pneumonia classification framework.Scientific reports · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Early evaluation and diagnosis can significantly reduce the life-threatening nature of lung diseases. Computer-aided diagnostic systems (CADs) can help radiologists make more precise diagnoses and reduce misinterpretations in lung disease diagnosis. Existing literature indicates that more research is needed to correctly classify lung diseases in the presence of multiple classes for different radiographic imaging datasets. As a result, this paper proposes RVCNet, a hybrid deep neural network framework for predicting lung diseases from an X-ray dataset of multiple classes. This framework is developed based on the ideas of three deep learning techniques: ResNet101V2, VGG19, and a basic CNN model. In the feature extraction phase of this new hybrid architecture, hyperparameter fine-tuning is used. Additional layers, such as batch normalization, dropout, and a few dense layers, are applied in the classification phase. The proposed method is applied to a dataset of COVID-19, non-COVID lung infections, viral pneumonia, and normal patients' X-ray images. The experiments take into account 2262 training and 252 testing images. Results show that with the Nadam optimizer, the proposed algorithm has an overall classification accuracy, AUC, precision, recall, and F1-score of 91.27%, 92.31%, 90.48%, 98.30%, and 94.23%, respectively. Finally, these results are compared with some recent deep-learning models. For this four-class dataset, the proposed RVCNet has a classification accuracy of 91.27%, which is better than ResNet101V2, VGG19, VGG19 over CNN, and other stand-alone models. Finally, the application of the GRAD-CAM approach clearly interprets the classification of images by the RVCNet framework.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.